Relationship Between Major Depression Symptom Severity and Sleep Collected Using a Wristband Wearable Device: Multicenter Longitudinal Observational Study.


Journal

JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439

Informations de publication

Date de publication:
12 04 2021
Historique:
received: 26 09 2020
accepted: 03 02 2021
revised: 07 12 2020
entrez: 12 4 2021
pubmed: 13 4 2021
medline: 22 5 2021
Statut: epublish

Résumé

Sleep problems tend to vary according to the course of the disorder in individuals with mental health problems. Research in mental health has associated sleep pathologies with depression. However, the gold standard for sleep assessment, polysomnography (PSG), is not suitable for long-term, continuous monitoring of daily sleep, and methods such as sleep diaries rely on subjective recall, which is qualitative and inaccurate. Wearable devices, on the other hand, provide a low-cost and convenient means to monitor sleep in home settings. The main aim of this study was to devise and extract sleep features from data collected using a wearable device and analyze their associations with depressive symptom severity and sleep quality as measured by the self-assessed Patient Health Questionnaire 8-item (PHQ-8). Daily sleep data were collected passively by Fitbit wristband devices, and depressive symptom severity was self-reported every 2 weeks by the PHQ-8. The data used in this paper included 2812 PHQ-8 records from 368 participants recruited from 3 study sites in the Netherlands, Spain, and the United Kingdom. We extracted 18 sleep features from Fitbit data that describe participant sleep in the following 5 aspects: sleep architecture, sleep stability, sleep quality, insomnia, and hypersomnia. Linear mixed regression models were used to explore associations between sleep features and depressive symptom severity. The z score was used to evaluate the significance of the coefficient of each feature. We tested our models on the entire dataset and separately on the data of 3 different study sites. We identified 14 sleep features that were significantly (P<.05) associated with the PHQ-8 score on the entire dataset, among them awake time percentage (z=5.45, P<.001), awakening times (z=5.53, P<.001), insomnia (z=4.55, P<.001), mean sleep offset time (z=6.19, P<.001), and hypersomnia (z=5.30, P<.001) were the top 5 features ranked by z score statistics. Associations between sleep features and PHQ-8 scores varied across different sites, possibly due to differences in the populations. We observed that many of our findings were consistent with previous studies, which used other measurements to assess sleep, such as PSG and sleep questionnaires. We demonstrated that several derived sleep features extracted from consumer wearable devices show potential for the remote measurement of sleep as biomarkers of depression in real-world settings. These findings may provide the basis for the development of clinical tools to passively monitor disease state and trajectory, with minimal burden on the participant.

Sections du résumé

BACKGROUND
Sleep problems tend to vary according to the course of the disorder in individuals with mental health problems. Research in mental health has associated sleep pathologies with depression. However, the gold standard for sleep assessment, polysomnography (PSG), is not suitable for long-term, continuous monitoring of daily sleep, and methods such as sleep diaries rely on subjective recall, which is qualitative and inaccurate. Wearable devices, on the other hand, provide a low-cost and convenient means to monitor sleep in home settings.
OBJECTIVE
The main aim of this study was to devise and extract sleep features from data collected using a wearable device and analyze their associations with depressive symptom severity and sleep quality as measured by the self-assessed Patient Health Questionnaire 8-item (PHQ-8).
METHODS
Daily sleep data were collected passively by Fitbit wristband devices, and depressive symptom severity was self-reported every 2 weeks by the PHQ-8. The data used in this paper included 2812 PHQ-8 records from 368 participants recruited from 3 study sites in the Netherlands, Spain, and the United Kingdom. We extracted 18 sleep features from Fitbit data that describe participant sleep in the following 5 aspects: sleep architecture, sleep stability, sleep quality, insomnia, and hypersomnia. Linear mixed regression models were used to explore associations between sleep features and depressive symptom severity. The z score was used to evaluate the significance of the coefficient of each feature.
RESULTS
We tested our models on the entire dataset and separately on the data of 3 different study sites. We identified 14 sleep features that were significantly (P<.05) associated with the PHQ-8 score on the entire dataset, among them awake time percentage (z=5.45, P<.001), awakening times (z=5.53, P<.001), insomnia (z=4.55, P<.001), mean sleep offset time (z=6.19, P<.001), and hypersomnia (z=5.30, P<.001) were the top 5 features ranked by z score statistics. Associations between sleep features and PHQ-8 scores varied across different sites, possibly due to differences in the populations. We observed that many of our findings were consistent with previous studies, which used other measurements to assess sleep, such as PSG and sleep questionnaires.
CONCLUSIONS
We demonstrated that several derived sleep features extracted from consumer wearable devices show potential for the remote measurement of sleep as biomarkers of depression in real-world settings. These findings may provide the basis for the development of clinical tools to passively monitor disease state and trajectory, with minimal burden on the participant.

Identifiants

pubmed: 33843591
pii: v9i4e24604
doi: 10.2196/24604
pmc: PMC8076992
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e24604

Subventions

Organisme : Alzheimer's Society
ID : 171
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17214
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R016372/1
Pays : United Kingdom

Informations de copyright

©Yuezhou Zhang, Amos A Folarin, Shaoxiong Sun, Nicholas Cummins, Rebecca Bendayan, Yatharth Ranjan, Zulqarnain Rashid, Pauline Conde, Callum Stewart, Petroula Laiou, Faith Matcham, Katie M White, Femke Lamers, Sara Siddi, Sara Simblett, Inez Myin-Germeys, Aki Rintala, Til Wykes, Josep Maria Haro, Brenda WJH Penninx, Vaibhav A Narayan, Matthew Hotopf, Richard JB Dobson, RADAR-CNS Consortium. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 12.04.2021.

Références

Am J Psychiatry. 1972 Apr;128(10):1303-5
pubmed: 4335278
Curr Psychiatry Rep. 2004 Dec;6(6):430-7
pubmed: 15538991
Sleep Med Rev. 2009 Aug;13(4):275-85
pubmed: 19269201
Sleep Health. 2017 Feb;3(1):6-19
pubmed: 28346153
JMIR Mhealth Uhealth. 2019 Aug 01;7(8):e11734
pubmed: 31373275
J Occup Environ Med. 2004 Jun;46(6 Suppl):S46-55
pubmed: 15194895
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
J Med Internet Res. 2019 Nov 28;21(11):e16273
pubmed: 31778122
Harv Rev Psychiatry. 2008;16(5):287-98
pubmed: 18803104
Physiol Rev. 2013 Apr;93(2):681-766
pubmed: 23589831
Neurol Ther. 2013 Mar 13;2(1-2):25-42
pubmed: 26000214
Compr Psychiatry. 2014 Feb;55(2):319-25
pubmed: 24267542
Sleep. 2013 Jul 1;36(7):1059-1068
pubmed: 23814343
BMC Psychiatry. 2019 Feb 18;19(1):72
pubmed: 30777041
Biometrics. 1982 Dec;38(4):963-74
pubmed: 7168798
Chronobiol Int. 2018 Apr;35(4):465-476
pubmed: 29235907
J Sleep Res. 2011 Mar;20(1 Pt 2):183-200
pubmed: 20374444
Behav Sleep Med. 2015;13(6):472-90
pubmed: 25117292
J Clin Sleep Med. 2010 Feb 15;6(1):21-9
pubmed: 20191934
J Affect Disord. 1997 Jun;44(1):39-44
pubmed: 9186801
Pediatrics. 2008 Jun;121(6):1165-73
pubmed: 18519486
J Affect Disord. 2009 Apr;114(1-3):163-73
pubmed: 18752852
Int J Ment Health Syst. 2007 Sep 04;1(1):4
pubmed: 18271976
Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:1507-10
pubmed: 18002253
Biol Psychol. 2001 Jul-Aug;57(1-3):67-103
pubmed: 11454435
Physiol Meas. 2017 Oct 31;38(11):1968-1979
pubmed: 29087960
Psychol Med. 2020 May;50(7):1129-1138
pubmed: 31044683
Am J Psychiatry. 1989 Mar;146(3):329-33
pubmed: 2919689
Sleep Med Rev. 2013 Oct;17(5):377-90
pubmed: 23391633
JMIR Mhealth Uhealth. 2019 Jun 06;7(6):e13384
pubmed: 31172956
J Affect Disord. 2004 Jan;78(1):27-35
pubmed: 14672794
Curr Psychiatry Rep. 2005 Jun;7(3):196-200
pubmed: 15935133
J Med Internet Res. 2020 Sep 25;22(9):e19992
pubmed: 32877352

Auteurs

Yuezhou Zhang (Y)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Amos A Folarin (AA)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Institute of Health Informatics, University College London, London, United Kingdom.
South London and Maudsley National Health Services Foundation Trust, London, United Kingdom.

Shaoxiong Sun (S)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Nicholas Cummins (N)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Rebecca Bendayan (R)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
South London and Maudsley National Health Services Foundation Trust, London, United Kingdom.

Yatharth Ranjan (Y)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Zulqarnain Rashid (Z)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Pauline Conde (P)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Callum Stewart (C)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Petroula Laiou (P)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Faith Matcham (F)

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Katie M White (KM)

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Femke Lamers (F)

Department of Psychiatry, Amsterdam Public Health Research Institute and Amsterdam Neuroscience, Amsterdam University Medical Centre, Vrije Universiteit and GGZ inGeest, Amsterdam, Netherlands.

Sara Siddi (S)

Teaching Research and Innovation Unit, Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.
Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.

Sara Simblett (S)

Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Inez Myin-Germeys (I)

Center for Contextual Psychiatry, Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Belgium.

Aki Rintala (A)

Center for Contextual Psychiatry, Department of Neurosciences, Katholieke Universiteit Leuven, Leuven, Belgium.
Faculty of Social Services and Health Care, LAB University of Applied Sciences, Lahti, Finland.

Til Wykes (T)

South London and Maudsley National Health Services Foundation Trust, London, United Kingdom.
Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Josep Maria Haro (JM)

Teaching Research and Innovation Unit, Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, Barcelona, Spain.
Centro de Investigación Biomédica en Red de Salud Mental, Madrid, Spain.
Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Spain.

Brenda Wjh Penninx (BW)

Department of Psychiatry, Amsterdam Public Health Research Institute and Amsterdam Neuroscience, Amsterdam University Medical Centre, Vrije Universiteit and GGZ inGeest, Amsterdam, Netherlands.

Vaibhav A Narayan (VA)

Janssen Research and Development LLC, Titusville, NJ, United States.

Matthew Hotopf (M)

South London and Maudsley National Health Services Foundation Trust, London, United Kingdom.
Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Richard Jb Dobson (RJ)

Department of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Institute of Health Informatics, University College London, London, United Kingdom.
South London and Maudsley National Health Services Foundation Trust, London, United Kingdom.
see Acknowledgments, .

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH